Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study-Reference-Cited by-同舟云学术

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

Published:2012-06-19 Issue:7 Volume:27 Page:1233-1240
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Ogawa Eiichi,Furusyo Norihiro,Kajiwara Eiji,Takahashi Kazuhiro,Nomura Hideyuki,Tanabe Yuichi,Satoh Takeaki,Maruyama Toshihiro,Nakamuta Makoto,Kotoh Kazuhiro,Azuma Koichi,Dohmen Kazufumi,Shimoda Shinji,Hayashi Jun,

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2011.06965.x/fullpdf

Reference31 articles.

1. Natural history of chronic hepatitis C;Sheff;Hepatology,2002

2. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection;Hayashi;Hepatology,1997

3. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial;Davis;N. Engl. J. Med.,1989

4. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C;Hayashi;Am. J. Gastroenterol.,1994

5. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin;Ogawa;Antiviral Res.,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C;JAMA Internal Medicine;2023-02-01

2. Forms and Methods for Interferon’s Encapsulation;Pharmaceutics;2021-09-22

3. Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals;Journal of Gastroenterology and Hepatology;2021-08-23

4. Advancements in combination therapy of Hepatitis C virus;pakistan journal of pharmaceutical sciences;2020-09-01

5. Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals;The Journal of Infectious Diseases;2020-06-25